10-Hydroxy-2-decenoic acid inhibiting the proliferation of fibroblast-like synoviocytes by PI3K-AKT pathway

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 97-104

  Wang, Jianguang ^a   Zhang, Wei ^a   Zou, Hai ^a   Lin, Yaoyao ^a   Lin, Ke ^a   Zhou, Zhonghao ^a   Qiang, Jiaping ^a   Lin, Jialiang ^a   Chuka, Chifundo Martha ^a   Ge, Renshan ^a   Zhao, Shujiang ^c   Yang, Xinyu ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Chashan University Town   (China)

^c ZHEJIANG OCEAN UNIVERSITY   (China)

Author keywords

10H2DA; HDACIs; Microarray; PI3K AKT pathway; Rheumatoid arthritis

Indexed keywords

10 HYDROXY 2 DECENOIC ACID; CYTOKINE; CYTOKINE RECEPTOR; HISTONE DEACETYLASE 1; HISTONE H3; HISTONE H4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; 10-HYDROXY-2-DECENOIC ACID; HISTONE; HISTONE DEACETYLASE; MONOUNSATURATED FATTY ACID; ONCOPROTEIN;

ARTICLE; ASSAY; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST LIKE SYNOVIOCYTE; GENE EXPRESSION; HDAC ACTIVITY ASSAY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MTT ASSAY; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; WESTERN BLOTTING; ACETYLATION; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENETICS; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SYNOVIAL FLUID;

ACETYLATION; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, MONOUNSATURATED; FIBROBLASTS; GENE EXPRESSION; HISTONE DEACETYLASES; HISTONES; HUMANS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PRIMARY CELL CULTURE; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; SYNOVIAL FLUID;

EID: 84930946698     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.05.036     Document Type: Article

References (53)

1. C.H. Opava, and M. Bjork Towards evidence-based hand exercises in rheumatoid arthritis Lancet. 385 2015 396 398
2. M. Takikawa, A. Kumagai, H. Hirata, M. Soga, Y. Yamashita, and M. Ueda 10-Hydroxy-2-decenoic acid, a unique medium-chain fatty acid, activates 5'-AMP-activated protein kinase in L6 myotubes and mice Mol. Nutr. Food Res. 57 2013 1794 1802
3. G.F. Townsend, W.H. Brown, E.E. Felauer, and B. Hazlett Studies on the in vitro antitumor activity of fatty acids. IV. The esters of acids closely related to 10-hydroxy-2-decenoic acids from royal jelly against transplantable mouse leukemia Can. J. Biochem. Physiol. 39 1961 1765 1770
4. G.F. Townsend, J.F. Morgan, and B. Hazlett Activity of 10-hydroxydecenoic acid from royal jelly against experimental leukaemia and ascitic tumours Nature 183 1959 1270 1271
5. G.F. Townsend, J.F. Morgan, S. Tolnai, B. Hazlett, H.J. Morton, and R.W. Shuel Studies on the in vitro antitumor activity of fatty acids. I. 10-Hydroxy-2-decenoic acid from royal jelly Cancer Res. 20 1960 503 510
6. M.S. Blum, A.F. Novak, and S. Taber III 10-Hydroxy-delta 2-decenoic acid, an antibiotic found in royal jelly Science 130 1959 452 453
7. D. Xu, X. Mei, and S. Xu The research of 10-hydroxy-2-decenoic acid on experiment hyperlipoidemic rat Zhong Yao Cai 25 2002 346 347
8. N. Hattori, H. Nomoto, H. Fukumitsu, S. Mishima, and S. Furukawa Royal jelly and its unique fatty acid, 10-hydroxy-trans-2-decenoic acid, promote neurogenesis by neural stem/progenitor cells in vitro Biomed. Res. 28 2007 261 266
9. H. Izuta, Y. Chikaraishi, M. Shimazawa, S. Mishima, and H. Hara 10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells Evid. Based Complement. Alternat. Med. 6 2009 489 494
10. S. Koya-Miyata, I. Okamoto, S. Ushio, K. Iwaki, M. Ikeda, and M. Kurimoto Identification of a collagen production-promoting factor from an extract of royal jelly and its possible mechanism Biosci. Biotechnol. Biochem. 68 2004 767 773
11. D. Vucevic, E. Melliou, S. Vasilijic, S. Gasic, P. Ivanovski, and I. Chinou Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro Int. Immunopharmacol. 7 2007 1211 1220
12. K. Takahashi, T. Sugiyama, S. Tokoro, P. Neri, and H. Mori Inhibition of interferon-gamma-induced nitric oxide production by 10-hydroxy-trans-2-decenoic acid through inhibition of interferon regulatory factor-8 induction Cell. Immunol. 273 2012 73 78
13. K. Takahashi, T. Sugiyama, S. Tokoro, P. Neri, and H. Mori Inhibitory effect of 10-hydroxydecanoic acid on lipopolysaccharide-induced nitric oxide production via translational downregulation of interferon regulatory factor-1 in RAW264 murine macrophages Biomed. Res. 34 2013 205 214
14. P. Moutsatsou, Z. Papoutsi, E. Kassi, N. Heldring, C. Zhao, and A. Tsiapara Fatty acids derived from royal jelly are modulators of estrogen receptor functions PLoS One. 5 2010 e15594
15. X.Y. Yang, D.S. Yang, Z. Wei, J.M. Wang, C.Y. Li, and Y. Hui 10-Hydroxy-2-decenoic acid from royal jelly: a potential medicine for RA J. Ethnopharmacol. 128 2010 314 321
16. J.G. Wang, J. Ruan, C.Y. Li, J.M. Wang, Y. Li, and W.T. Zhai Connective tissue growth factor, a regulator related with 10-hydroxy-2-decenoic acid down-regulate MMPs in rheumatoid arthritis Rheumatol. Int. 32 2011 2791 2799
17. L.C. Huber, J. Stanczyk, A. Jungel, and S. Gay Epigenetics in inflammatory rheumatic diseases Arthritis Rheum. 56 2007 3523 3531
18. M.D. Shahbazian, and M. Grunstein Functions of site-specific histone acetylation and deacetylation Annu. Rev. Biochem. 76 2007 75 100
19. A.M. Grabiec, S. Krausz, W. de Jager, T. Burakowski, D. Groot, and M.E. Sanders Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue J. Immunol. 184 2010 2718 2728
20. J. Gillespie, S. Savic, C. Wong, A. Hempshall, M. Inman, and P. Emery Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients Arthritis Rheum. 64 2012 418 422
21. Y.L. Chung, M.Y. Lee, A.J. Wang, and L.F. Yao A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis Mol. Ther. 8 2003 707 717
22. K. Nishida, T. Komiyama, S. Miyazawa, Z.N. Shen, T. Furumatsu, and H. Doi Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression Arthritis Rheum. 50 2004 3365 3376
23. A. Spannhoff, Y.K. Kim, N.J. Raynal, V. Gharibyan, M.B. Su, and Y.Y. Zhou Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees EMBO Rep. 12 2011 238 243
24. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, and N.S. Cooper The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum. 31 1988 315 324
25. J.G. Wang, W.D. Xu, W.T. Zhai, Y. Li, J.W. Hu, and B. Hu Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis: a comparative proteomics study Arthritis Rheum. 64 2012 993 1004
26. G.W. Wright, and R.M. Simon A random variance model for detection of differential gene expression in small microarray experiments Bioinformatics 19 2003 2448 2455
27. H. Yang, N. Crawford, L. Lukes, R. Finney, M. Lancaster, and K.W. Hunter Metastasis predictive signature profiles pre-exist in normal tissues Clin. Exp. Metastasis 22 2005 593 603
28. R. Clarke, H.W. Ressom, A. Wang, J. Xuan, M.C. Liu, and E.A. Gehan The properties of high-dimensional data spaces: implications for exploring gene and protein expression data Nat. Rev. Cancer 8 2008 37 49
29. The Gene Ontology (GO) project in 2006 Nucleic Acids Res. 34 2006 D322 D326
30. M. Ashburner, C.A. Ball, J.A. Blake, D. Botstein, H. Butler, and J.M. Cherry Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genet. 25 2000 25 29
31. D. Dupuy, N. Bertin, C.A. Hidalgo, K. Venkatesan, D. Tu, and D. Lee Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans Nat. Biotechnol. 25 2007 663 668
32. T. Schlitt, K. Palin, J. Rung, S. Dietmann, M. Lappe, and E. Ukkonen From gene networks to gene function Genome Res. 13 2003 2568 2576
33. M. Kanehisa, S. Goto, S. Kawashima, Y. Okuno, and M. Hattori The KEGG resource for deciphering the genome Nucleic Acids Res. 32 2004 D277 D280
34. M. Yi, J.D. Horton, J.C. Cohen, H.H. Hobbs, and R.M. Stephens WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data BMC Bioinformatics 7 2006 30
35. S. Draghici, P. Khatri, A.L. Tarca, K. Amin, A. Done, and C. Voichita A systems biology approach for pathway level analysis Genome Res. 17 2007 1537 1545
36. S. Toyama, N. Tamura, K. Haruta, T. Karakida, S. Mori, and T. Watanabe Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice Arthritis Res. Ther. 12 2010 R92
37. B. Bartok, D.L. Boyle, Y. Liu, P. Ren, S.T. Ball, and W.D. Bugbee PI3 kinase delta is a key regulator of synoviocyte function in rheumatoid arthritis Am. J. Pathol. 180 2012 1906 1916
38. G.R. Burmester, E. Feist, and T. Dorner Emerging cell and cytokine targets in rheumatoid arthritis Nat. Rev. Rheumatol. 10 2014 77 88
39. D.E. Furst, and P. Emery Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets Rheumatology (Oxford) 53 2014 1560 1569
40. T. Pap, W.H. van der Laan, K.R. Aupperle, R.E. Gay, J.H. Verheijen, and G.S. Firestein Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis Arthritis Rheum. 43 2000 2531 2536
41. F. Blanchard, and C. Chipoy Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov. Today 10 2005 197 204
42. H. Maciejewska-Rodrigues, E. Karouzakis, S. Strietholt, H. Hemmatazad, M. Neidhart, and C. Ospelt Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression J. Autoimmun. 35 2010 15 22
43. L.C. Huber, M. Brock, H. Hemmatazad, O.T. Giger, F. Moritz, and M. Trenkmann Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients Arthritis Rheum. 56 2007 1087 1093
44. H. Maciejewska Rodrigues, A. Jungel, R.E. Gay, and S. Gay Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis Mol. Immunol. 47 2009 12 18
45. T. Kawabata, K. Nishida, K. Takasugi, H. Ogawa, K. Sada, and Y. Kadota Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis Arthritis Res. Ther. 12 2010 R133
46. M. Horiuchi, A. Morinobu, T. Chin, Y. Sakai, M. Kurosaka, and S. Kumagai Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts J. Rheumatol. 36 2009 1580 1589
47. A. Jungel, V. Baresova, C. Ospelt, B.R. Simmen, B.A. Michel, and R.E. Gay Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis Ann. Rheum. Dis. 65 2006 910 912
48. Q.Y. Choo, P.C. Ho, Y. Tanaka, and H.S. Lin Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells Rheumatology (Oxford) 49 2010 1447 1460
49. S. Hayer, N. Pundt, M.A. Peters, C. Wunrau, I. Kuhnel, and K. Neugebauer PI3Kgamma regulates cartilage damage in chronic inflammatory arthritis FASEB J. 23 2009 4288 4298
50. C. Yu, G. Dasmahapatra, P. Dent, and S. Grant Synergistic interactions between MEK1/2 and histone deacetylase inhibitors in BCR/ABL + human leukemia cells Leukemia 19 2005 1579 1589
51. M. Rahmani, E. Reese, Y. Dai, C. Bauer, S.G. Payne, and P. Dent Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species Cancer Res. 65 2005 2422 2432
52. M. Rahmani, C. Yu, Y. Dai, E. Reese, W. Ahmed, and P. Dent Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells Cancer Res. 63 2003 8420 8427
53. N. Gao, M. Rahmani, X. Shi, P. Dent, and S. Grant Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress Blood 107 2006 241 249